Diabetes Multimedia Compendium

Diabetes Compendium

Multimedia

Zachary Bloomgarden, MD; Robert Gabbay, MD, PhD, FACP; Silvio Inzucchi, MD; Dennis P. Scanlon, PhD; and Kenneth Snow, MD, MBA, provide additional insight on clinical data and the management of patients with diabetes at risk for cardiovascular events, and consider how the costs of emerging agents affect payers’ decisions regarding coverage for therapy.
Robert Gabbay, MD, PhD, FACP; Dennis P. Scanlon, PhD; and Kenneth Snow, MD, MBA, remark that with new and constantly improving technologies on the market, only some have demonstrated evidence in clinical trials that they improve outcomes and reduce costs.
Robert Gabbay, MD, PhD, FACP; Mary Ann Hodorowicz, RDN, MBA, CDE; Neal Kaufman, MD; Dennis P. Scanlon, PhD; and Kenneth Snow, MD, MBA, explain that the use of tools in diabetes care requires a partnership between good technology and a patient who is ready and willing to use it, and the next phase will involve technology that gives patients feedback from data at the point of care.
In this segment, Robert Gabbay, MD, PhD, FACP; Mary Ann Hodorowicz, RDN, MBA, CDE; Dennis P. Scanlon, PhD; and Kenneth Snow, MD, MBA, discuss the cost of an event of hypoglycemia. The panelists also consider how continuous glucose monitoring (CGM) can reduce the number of events, and explain the FDA’s recent decision on CGM dosing with the Dexcom G5.
Robert Gabbay, MD, PhD, FACP; Mary Ann Hodorowicz, RDN, MBA, CDE; Neal Kaufman, MD; Dennis P. Scanlon, PhD; and Kenneth Snow, MD, MBA, suggest that technology can help bring the Diabetes Prevention Program to new populations; and smartphones, in particular, can help make diabetes prevention highly accessible.
In this AJMC® Peer ExchangeTM, moderator Dennis P. Scanlon, PhD, introduces panelists Zachary Bloomgarden, MD; Robert Gabbay, MD, PhD, FACP; Mary Ann Hodorowicz, RDN, MBA, CDE; and Kenneth Snow, MD, MBA, to the discussion of the benefits and access issues of today’s new insulin therapies and combinations to treat diabetes.
Zachary Bloomgarden, MD; Robert Gabbay, MD, PhD, FACP; Silvio Inzucchi, MD; and Dennis P. Scanlon, PhD, reflect on results of the CVD-REAL study and discuss the usefulness of observational data in future diabetes/heart failure research.
Compendia
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
$AD300x250BB$
$vacMongoViewPlus$